SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Choose external intimate hygiene without ambiguous internal-use claims

Clarify body area, intended use, fragrance burden, and stop conditions before comparing external hygiene products.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Clean the intimate area externally and simply

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • A product intended for external use should not be used internally.
  • Persistent odor, pain, or discomfort should not be covered up by fragrance.

WHAT WE ARE NOT CLAIMING

  • Exact concentrations, material origin and quality, reformulation history, and online ingredient-list synchronization are often missing.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Clean the intimate area externally and simply

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

A product intended for external use should not be used internally.

Exact concentrations, material origin and quality, reformulation history, and online ingredient-list synchronization are often missing.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. 21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
  6. FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration
  7. How bad is fragrance in feminine washes?Auteur supprimé — Reddit r/hygiene
Data and test conditions still required
Product function and category

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Ingredient list for the current version

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Fragrance and declared allergens

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Body area and directions

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Amount, contact time, and frequency

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Regulatory status and applicable labeling

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Tolerance protocol and stop criteria

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Classify status by intended use and claim

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Assess general tolerance with stop rules

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Trace allergen disclosure to the product version

Define and retain the conditions, date, material, and outcome before presenting any owned observation.